[Multiple evanescent white dot syndrome and multiple sclerosis]

J Fr Ophtalmol. 2011 Apr;34(4):252-5. doi: 10.1016/j.jfo.2010.11.001. Epub 2011 Mar 17.
[Article in French]

Abstract

Purpose: To describe a patient who fulfilled the criteria for both clinically definite multiple evanescent white dot syndrome (MEWDS) and multiple sclerosis.

Methods: We performed a complete ophthalmologic and neurological examination in a 30-year-old woman who was referred to our department for blurred vision in her left eye (LE) with photopsia.

Results: Following a complete ophthalmologic examination, the patient was diagnosed with MEWDS and coincident multiple sclerosis. She underwent therapy with intravenous methylprednisolone (1000 mg/day) for three days, followed by oral prednisone (1 mg/kg per day) for 15 days. Most of the symptoms and signs apparently regressed within one month, despite a still abnormal OCT macular scan, probably due to atrophic post-inflammatory changes in the outer and photoreceptor layers (rods and cones).

Conclusion: This report, showing the clinical features of MEWDS associated with multiple sclerosis, strongly suggests common neuropathological and inflammatory mechanisms between MS and white dot syndromes.

Publication types

  • English Abstract

MeSH terms

  • Administration, Oral
  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Brain / pathology
  • Chorioretinitis / diagnosis*
  • Chorioretinitis / drug therapy
  • Diplopia / etiology
  • Drug Therapy, Combination
  • Electroretinography / drug effects
  • Evoked Potentials, Visual / drug effects
  • Evoked Potentials, Visual / physiology
  • Female
  • Fluorescein Angiography
  • Humans
  • Magnetic Resonance Imaging
  • Methylprednisolone / administration & dosage
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / drug therapy
  • Optic Neuritis / diagnosis*
  • Optic Neuritis / drug therapy
  • Papilledema / diagnosis
  • Papilledema / drug therapy
  • Prednisone / administration & dosage
  • Tomography, Optical Coherence
  • Visual Field Tests

Substances

  • Anti-Inflammatory Agents
  • Prednisone
  • Methylprednisolone